Introduction Of Olaparix 150 Mg
Olaparix 150 mg is an advanced oral cancer medicine used to treat several types of cancers, including ovarian, breast, prostate, and pancreatic cancer. It is the generic version of Olaparib.It works by targeting and inhibiting PARP (poly ADP-ribose polymerase) enzymes that help block cancer cell repair and growth. By stopping the PARP enzyme in the cancer cell’s DNA repair process, it helps kill cancer cells more effectively, especially in people with BRCA gene mutations.
This generic version of Olaparib, which is globally recognized under the brand name Lynparza. Manufactured by Beacon Pharmaceuticals Ltd, Olaparix is trusted by patients and doctors for its effectiveness and affordability.
If you’re looking to buy Olaparix online, Unit Pharmacy offers authentic Olaparix 150 mg tablets at a competitive price, with fast worldwide shipping.
Who Makes Olaparix 150 mg?
Olaparix 150 mg is manufactured by Beacon Pharmaceuticals Ltd, a leading Bangladeshi pharmaceutical company with global recognition for its high-quality oncology products. Beacon is known for producing affordable generic cancer medicines while maintaining international standards.
Pharmaceutical Formulation of Olaparix 150 Mg
The pharmaceutical formulation of Olaparix 150 mg combines targeted cancer-fighting efficacy with optimized bioavailability. Designed for precision, every tablet delivers consistent Olaparib exposure to support advanced cancer therapy with ease and reliability.
Key formulation details:
- Active Ingredient: Olaparib 150 mg
- Dosage Form: Film-coated oral tablet
- Appearance: Pink to reddish, oval-shaped tablet for easy swallowing
- Excipients: Includes standard pharmaceutical-grade binders, fillers, and coating agents to enhance tablet integrity and bioavailability
- Administration Route: Oral, with or without food
Composition (Excipients may include)
- Lactose Monohydrate
- Microcrystalline Cellulose
- Croscarmellose Sodium
- Colloidal Silicon Dioxide
- Magnesium Stearate
- Hypromellose
- Titanium Dioxide
- Polyethylene Glycol
- Iron Oxide Red and Yellow (coloring agents)
These excipients are used to enhance the stability, absorption, and shelf-life of the product. The tablet’s coating ensures easy swallowing and consistent Olaparix 150 mg release in the body.
Indications: What is Olaparix Used For?
Olaparix 150 mg is prescribed for the treatment of:
- Advanced Ovarian Cancer
- HER2-negative Breast Cancer with BRCA mutation
- Metastatic Prostate Cancer
- Pancreatic Cancer with BRCA gene mutation
These indications are supported by global health authorities, including FDA approval for Olaparib, making Olaparix 150 mg a reliable and effective choice for targeted therapy.
Why doctors choose Olaparix:
- Clinically Proven: Effective against BRCA-mutated ovarian, breast, prostate, and pancreatic cancers.
- Targeted Therapy: Works by blocking PARP enzymes, leading to precise cancer cell destruction.
- Oral Convenience: Easy-to-take tablets improve patient compliance.
- Affordable Alternative: Cost-effective option compared to branded Olaparib (Lynparza).
Who Should Use Olaparix?
Olaparix (Olaparib) is recommended for patients who:
- Have BRCA-mutated cancers such as ovarian, breast, prostate, or pancreatic cancer.
- Require maintenance therapy after initial chemotherapy success.
- Need targeted treatment when traditional options have limited effectiveness.
- Prefer oral medications over hospital-based injectable therapies.
- Seek affordable access to high-quality Olaparib without compromising efficacy.
Mechanism of Action: How Does Olaparix Work?
Olaparix 150 mg, a generic form of Olaparib, works by targeting and inhibiting an enzyme called PARP (poly ADP-ribose polymerase). PARP enzymes help cancer cells repair their damaged DNA and continue growing. By blocking PARP, Olaparix prevents cancer cells—especially those with BRCA1 or BRCA2 mutations from fixing their DNA damage, leading to cell death.
This targeted mechanism makes Olaparix (Olaparib) especially effective in treating certain types of ovarian, breast, pancreatic, and prostate cancers. Unlike traditional chemotherapy, which affects both healthy and cancerous cells, Olaparix 150 mg tablets focus on defective cells, reducing harm to healthy tissues.
By interfering with DNA repair, Olaparix 150 mg enhances cancer cell sensitivity to damage, slows tumor growth, and supports longer disease control all while offering a more personalized approach to cancer treatment.
Dosage & Administration: How to Take Olaparix Safely
Olaparix 150 mg tablets should be taken exactly as prescribed by your oncologist. Following the correct dosage and administration routine is essential for maximizing its effectiveness while minimizing side effects.
Standard Recommended Dosage
- Typical dose: 300 mg per day (150 mg tablet taken twice daily)
- Form: Oral tablet
- Route: Swallow whole with water, with or without food
- Do not crush, chew, or split the tablet
How to Take Olaparix 150 mg Safely
- Take at the same time each day for consistent Olaparib levels in your body.
- If you miss a dose, take it as soon as you remember but skip it if it’s almost time for the next one. Never double the dose.
- Continue taking Olaparix as long as prescribed, even if you feel well. Discontinuation should only be done under medical advice.
- Regular blood tests may be required to monitor blood counts and organ function during treatment.
Dose Adjustments and Special Considerations
- Kidney or liver issues – Lower doses may be needed to prevent buildup.
- Severe side effects – Symptoms like anemia or fatigue may lead to dose reduction.
- Drug interactions – Some medicines affect how Olaparix works in the body.
- Elderly or low-weight patients – May need closer monitoring.
Your doctor may adjust your Olaparix dose if you experience side effects like fatigue, anemia, or nausea. In some cases, dose reduction is necessary for patients with kidney issues or those on certain medications.
Olaparix 150 mg tablets offer flexibility for tailored treatment, making it easier to manage cancer therapy at home with regular supervision.
Olaparix FDA Approval & Regulatory Status
Olaparib, the active ingredient in Olaparix 150 mg, is an FDA-approved PARP inhibitor developed by AstraZeneca under the brand name Lynparza®. It received step-by-step approvals for different cancer types over several years:
- December 2014 – FDA approved Olaparib for advanced ovarian cancer in women with germline BRCA mutations after 3+ lines of chemotherapy.
- August 2017 – Approved as maintenance therapy for ovarian cancer in patients responding to platinum-based chemo.
- January 2018 – Approved for HER2-negative metastatic breast cancer with BRCA mutation.
- December 2019 – Approved for metastatic pancreatic cancer in BRCA-mutated patients as first-line maintenance therapy.
- May 2020 – Approved for metastatic castration-resistant prostate cancer (mCRPC) with homologous recombination repair (HRR) gene mutations.
- November 2022 – Approved for adjuvant treatment of high-risk early breast cancer with BRCA mutation.
Olaparix 150 mg, as a high-quality generic version of Olaparib, aligns with these FDA-approved uses. It meets international regulatory and safety standards for oncology treatment.
Clinical Benefits of Olaparix 150 mg
Olaparix 150 mg (Olaparib) offers several clinically proven advantages for patients battling BRCA-mutated and advanced-stage cancers. Backed by global trials and FDA approvals, its benefits extend beyond tumor control to improved survival and treatment convenience.
1. Targeted DNA Repair Blockade
Olaparix inhibits the PARP enzyme, preventing cancer cells from repairing DNA damage, which leads to selective cancer cell death without harming healthy cells.
2. Proven Survival Benefit
Studies show that Olaparix extends progression-free survival (PFS) in ovarian, breast, pancreatic, and prostate cancer patients compared to placebo or conventional chemotherapy.
3. Maintenance Therapy Option
It is approved for use as maintenance therapy in ovarian and pancreatic cancers, helping delay recurrence after initial response to platinum-based chemotherapy.
4. Oral Administration for Long-Term Use
As an oral tablet, Olaparix 150 mg allows patients to continue treatment at home, reducing hospital visits and improving quality of life.
5. Effective Across Multiple Cancers
Olaparix is not limited to one cancer type; it is clinically effective in ovarian, breast, pancreatic, and prostate cancers, making it a multi-indication therapy.
6. Well-Tolerated Safety Profile
Compared to traditional chemotherapy, Olaparix generally causes fewer systemic side effects, making it suitable for long-term use in eligible patients.
7. BRCA-Mutated and HRR-Positive Tumor Response
It is especially effective in patients with BRCA1, BRCA2, or HRR gene mutations, providing a personalized treatment approach based on genetic profiling.
8. Reduces Risk of Disease Progression
Olaparix significantly delays disease progression, giving patients more time without cancer worsening, which is a critical goal in cancer management.
9. Supports Global Guidelines
Endorsed by NCCN, ESMO, and ASCO, Olaparip (and thus Olaparix 150 mg) is recommended in leading oncology clinical guidelines for targeted therapy.
Side Effects of Olaparix 150 mg
Like all cancer therapies, Olaparix 150 mg (Olaparib) may cause side effects, though not everyone experiences them the same way. Understanding potential side effects helps patients manage their treatment better and seek timely medical support.
Common Side Effects
These are usually mild to moderate and may improve over time:
- Fatigue or Weakness
The most reported side effect. Patients may feel tired, requiring more rest during the day. - Nausea and Vomiting
Olaparix may cause mild stomach upset. Taking tablets with food may help reduce discomfort. - Anemia (Low Red Blood Cell Count)
Regular blood tests are necessary as Olaparix can lower red blood cells, leading to tiredness or breathlessness. - Headache and Dizziness
Some patients report mild headaches or dizziness, especially in the early days of treatment. - Loss of Appetite or Weight Loss
Changes in eating habits can occur; nutritional support may be helpful.
Less Common but Serious Side Effects
- Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML)
Rare but serious blood disorders linked to long-term Olaparib use—especially in heavily pretreated patients. - Lung Inflammation (Pneumonitis)
Unexplained cough, difficulty breathing, or chest pain may indicate lung toxicity and require immediate medical attention. - Low Platelet or White Blood Cell Counts
This can increase the risk of infection or bleeding and must be monitored through blood tests. - Elevated Creatinine Levels
Kidney function may be temporarily affected; regular monitoring is recommended. - Taste Changes (Dysgeusia)
A metallic or altered taste is reported in some users, affecting appetite.
Monitoring and Management
- Regular CBC (complete blood count) and renal function tests are advised during treatment.
- Dose adjustment or treatment interruption may be necessary based on lab results or symptom severity.
- Inform your doctor immediately if you experience fever, bleeding, shortness of breath, or unusual fatigue.
What to Do
If you experience any unusual symptoms while taking Olaparix 150 mg, contact your doctor immediately. Never stop or change the dose without medical advice.
Pregnancy and Lactation
Olaparix (Olaparib) should not be used during pregnancy due to the risk of harm to the unborn baby. Women of childbearing potential should use effective contraception during and for 6 months after treatment. Breastfeeding is not recommended while taking Olaparix 150 mg tablets.
Precautions and Warnings
- Inform your doctor if you are pregnant or planning pregnancy.
- Avoid breastfeeding during and after treatment.
- Use effective birth control during treatment and for 6 months after.
- Tell your doctor if you have kidney or liver issues.
- Report all other medications or supplements you’re taking.
- Avoid alcohol and OTC drugs without medical advice.
- Regular blood tests are needed to monitor blood counts and organ function.
Overdose and Emergency Handling
In case of accidental overdose, symptoms may include severe nausea, fatigue, or dizziness. Seek immediate medical help. Do not attempt to self-treat or adjust your dosage without consulting a healthcare provider.
Pharmacological Class and Drug Category
Olaparix 150 mg belongs to the PARP inhibitor class, a breakthrough in targeted oncology treatment. It is part of a group of DNA damage response (DDR) targeted therapies, used when traditional treatments fail or are less effective.
Manufactured by Beacon Pharmaceuticals Ltd: Trusted Quality
Olaparix 150 mg is manufactured by Beacon Pharmaceuticals Ltd, a globally recognized Bangladeshi pharmaceutical company specializing in high-quality oncology medicines. Beacon follows strict WHO-GMP and international regulatory standards, ensuring consistent quality, safety, and efficacy in every batch.
Patients and healthcare providers trust Beacon for its clinical-grade manufacturing, proven treatment results, and its mission to make advanced cancer care more affordable and accessible worldwide.
What sets Beacon apart?
- Oncology Focused – Specializes in advanced cancer medicines.
- Global Standards – WHO-GMP certified manufacturing.
- Affordable Quality – Cost-effective alternatives to branded drugs.
- Trusted Worldwide – Exported to over 100 countries.
Beacon commitment to science, safety, and patient outcomes makes Tofacent not just accessible, but dependable.
Olaparix Price and Online Buying Guide
At Unit Pharmacy, Olaparix 150 Mg (Olaparib) is available for $755 USD per box. We ensure authenticity, affordability, and global shipping for patients seeking quality cancer care.
Current Price:
- $755 USD per box (Beacon Pharmaceuticals Ltd.)
- Includes pharmacist support and verified product details.
How to Buy Online:
- Visit unitpharmacy.com
- Add to cart → Checkout
- Choose shipping and payment options
- Prescription verified → Order shipped globally
Why Choose Us:
- 100% genuine Olaparib
- Affordable Olaparib alternative
- Trusted by patients worldwide
- Safe, fast, and discreet delivery
If you’re searching for “Olaparix online buy”, “Olaparib near me”, or an affordable Olaparib price, If any Unit Pharmacy delivers quality with care.
Olaparix Other Names and Alternatives
Olaparix 150 mg is a generic version of the well-known cancer drug Olaparib, originally marketed under the brand name Lynparza. While Olaparix is manufactured by Beacon Pharmaceuticals Ltd, the original patented product, Lynparza, is produced by AstraZeneca.
Other Names:
- Generic Name: Olaparib
- Brand Name: Lynparza
- International Generic Versions: Olaparix, Olanib, Olaparib Beacon
Popular Alternatives to Olaparix 150 mg:
- Lynparza® (AstraZeneca) – Original brand
- Olaparib Incepta – Generic by Incepta Pharmaceuticals
- Olanib 150 mg – By Everest Pharmaceuticals
- Olaparib Drug International Ltd – Another generic version
All these alternatives contain the same active ingredient, Olaparib, and are used for treating BRCA-mutated ovarian, breast, prostate, and pancreatic cancers.
Choosing Olaparix ensures access to a cost-effective, high-quality alternative to Lynparza, with similar efficacy and safety.
Supplier: Unit Pharmacy
Unit Pharmacy ensures that Olaparix 150 mg is readily available to healthcare providers and patients, offering reliable access to this essential targeted therapy. Their commitment to efficient supply and distribution supports effective management of BRCA-mutated cancers, helping to improve patient outcomes.
Why Buy Olaparix from Unit Pharmacy?
Unit Pharmacy is a trusted supplier of oncology medicines globally. We offer:
- 100% genuine Olaparib guaranteed.
- Transparent pricing: $755 USD per box.
- Easy and secure online ordering.
- Fast, worldwide shipping.
- Expert pharmacist support.
Storage Instructions
Store Olaparix tablets in a cool, dry place below 30°C. Keep away from moisture, sunlight, and out of reach of children. Do not use expired medicines.
Conclusion: Is Olaparix 150 Mg Right for You?
Olaparix 150 mg is a reliable and cost-effective choice for cancer patients needing Olaparib. With proven success in ovarian, breast, pancreatic, and prostate cancers, this treatment offers new hope where traditional therapies may fall short.
At Unit Pharmacy, we are committed to providing affordable Olaparib to patients around the globe. If you’re ready to start treatment, we’re here to help.
Take charge of your health today. Order Olaparix 150 Mg from our official page:
- Buy Now Unit Pharmacy.
Reviews
There are no reviews yet.